US Patent Issued to Bayer, The Broad Institute on Sept. 30 for "1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases" (German, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,153, issued on Sept. 30, was assigned to Bayer AG (Leverkusen, Germany) and The Broad Institute Inc. (Cambridge, Mass.).

"1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases" was invented by Stefan Nikolaus Gradl (Berlin), Manuel Ellermann (Berlin), Philip Lienau (Berlin), Charlotte Christine Kopitz (Falkensee, Germany), Martin Lange (Berlin), Adrian Tersteegen (Wuppertal, Germany), Detlev Sulzle (Berlin), Timothy A. Lewis (Cambridge, Mass.), Heidi Greulich (Cambridge, Mass.) and Xiaoyun Wu (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes name compounds of general formula...